Regulatory Guidance Monthly Review - March 2020
March 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
MRHA Guidance for Clinical Trials During COVID-19 Outbreak
MHRA Guidance On Clinical Trial Conduct During COVID-19 Pandemic
Regulatory Insights on COVID-19 Updates From FDA | 31 March 2020
FDA UPDATES - For Sponsors with Products Intended to Treat Indications Other than COVID-19
In...
Covid-19 Update from FDA | Conduct of Clinical Trials During Covid-19 Outbreak
FDA Guidance On Clinical Trial Conduct During COVID-19 Pandemic - 18 March 2020
Regulatory Guidance Monthly Review - February 2020
February 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - January 2020
January 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - December 2019
December 2019
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - November 2019
November 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a...
Selecting the Right EDC System for a Clinical Program
Understanding the Various Considerations for EDC Selection
Regulatory Guidance Monthly Review - October 2019
October 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a...